Growth Metrics

bioAffinity Technologies (BIAF) Consolidated Net Income: 2022-2025

Historic Consolidated Net Income for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to -$5.1 million.

  • bioAffinity Technologies' Consolidated Net Income fell 152.45% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 74.51%. This contributed to the annual value of -$9.0 million for FY2024, which is 13.89% down from last year.
  • Latest data reveals that bioAffinity Technologies reported Consolidated Net Income of -$5.1 million as of Q3 2025, which was down 24.39% from -$4.1 million recorded in Q2 2025.
  • bioAffinity Technologies' Consolidated Net Income's 5-year high stood at -$88,052 during Q2 2022, with a 5-year trough of -$5.1 million in Q3 2025.
  • In the last 3 years, bioAffinity Technologies' Consolidated Net Income had a median value of -$2.3 million in 2023 and averaged -$2.6 million.
  • Over the last 5 years, bioAffinity Technologies' Consolidated Net Income had its largest YoY gain of 53.43% in 2023, and its largest YoY loss of 1,876.30% in 2023.
  • Over the past 4 years, bioAffinity Technologies' Consolidated Net Income (Quarterly) stood at -$1.7 million in 2022, then plummeted by 41.72% to -$2.4 million in 2023, then decreased by 25.02% to -$3.0 million in 2024, then crashed by 152.45% to -$5.1 million in 2025.
  • Its last three reported values are -$5.1 million in Q3 2025, -$4.1 million for Q2 2025, and -$2.7 million during Q1 2025.